Skip Navigation


Hum. Reprod. Advance Access first published online on June 24, 2005
This version published online on July 28, 2005
Human Reproduction, doi:10.1093/humrep/dei119
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/10/2838    most recent
dei119v2
dei119v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Terriou, P.
Right arrow Articles by Roulier, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terriou, P.
Right arrow Articles by Roulier, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
Received January 20, 2005
Revised April 28, 2005
Accepted May 5, 2005

Article

Outcome of ICSI in HIV-1-infected women

P. Terriou 1*, P. Auquier 2, V. Chabert-Orsini 1, J.M. Chinchole 1, L. Cravello 3, C. Giorgetti 1, P. Halfon 4, J. Salzmann 1, and R. Roulier 1

1 Institut de Médecine de la Reproduction, 6 rue Rocca, 13008 Marseille
2 Laboratoire de Santé Publique de la Timone, Marseille
3 Maternité de l’hôpital de la Conception, Marseille
4 Laboratoire Alphabio, Hôpital Ambroise Paré, Marseille, France

* To whom correspondence should be addressed.
P. Terriou, E-mail: philippe.terriou{at}numericable.fr


  Abstract

BACKGROUND: Since 2001, French law has permitted the use of assisted reproductive technology in human immunodeficiency virus (HIV)-1 infected women under strict conditions. This report describes a preliminary series of sero-positive women who underwent assisted reproduction treatment at our facility. To minimize contamination of culture media, equipment, and therefore of male gametes and embryos, we chose to perform ICSI in all cases. The outcome of ICSI was compared with the outcome in an age-matched group of non-HIV-1-infected women. Since several previous reports have indicated that HIV infection may be associated with a decrease in spontaneous fertility, our goal was also to assess the fertility status of the HIV-1-infected women entering our ICSI programme. METHODS: The French law governing the use of assisted reproduction protocols in HIV-1-infected women was strictly applied. The inclusion criteria were absence of ongoing disease, CD4(+) count >200 cells/mm3, and stable HIV-1 RNA level. Since mean age at the time of ICSI was higher in HIV-1-infected women than in the overall group of non-HIV-infected women, we compared outcome data in HIV-1-infected women (group I) to a group of non-HIV-1-infected women matched with regard to age and follicle retrieval period (group II) as well as to the overall group of women who underwent ICSI at our institution (group III). RESULTS: A total of 66 ovarian stimulations was performed in 29 HIV-1-infected-infected women. The percentage of cancelled cycles was higher in infected women than in matched controls (15.2 versus 4.9%, P < 0.05). The duration of ovarian stimulation (13.3 versus 11.7 days, P < 0.05) and amount of recombinant FSH injected (2898 versus 2429 IU, P < 0.001) were also higher in infected women. The number of retrieved oocytes, mature oocytes, and embryos obtained as well as embryo quality was similar in all groups. The fertilization rate was higher in infected women than in matched controls (67 versus 60%, P < 0.01). The pregnancy rate was not significantly different between groups I and II (16.1 versus 19.6%) in spite of the fact that the number of embryos transferred was purposefully restricted in the HIV-1-infected group to minimize multiple pregnancy (2.0 versus 2.4, not significant). CONCLUSION: The results of this preliminary series of ICSI cycles in HIV-1-infected women indicate that optimal ovarian stimulation is slightly more difficult to achieve than in matched seronegative women. However, when criteria for oocyte retrieval were fulfilled, ICSI results were similar to those of age-matched controls.

Keywords: AIDS/fertility/HIV/ICSI/IVF/women.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
E. van Leeuwen, J.M. Prins, S. Jurriaans, K. Boer, P. Reiss, S. Repping, and F. van der Veen
Reproduction and fertility in human immunodeficiency virus type-1 infection
Hum. Reprod. Update, March 1, 2007; 13(2): 197 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Y. Manigart, S. Rozenberg, P. Barlow, M. Gerard, E. Bertrand, and A. Delvigne
ART outcome in HIV-infected patients
Hum. Reprod., November 1, 2006; 21(11): 2935 - 2940.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
V. Martinet, Y. Manigart, S. Rozenberg, B. Becker, M. Gerard, and A. Delvigne
Ovarian response to stimulation of HIV-positive patients during IVF treatment: a matched, controlled study
Hum. Reprod., May 1, 2006; 21(5): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.